** Shares of Adherium Ltd ADR.AX climb as much as 16.7% to
A$0.004, their highest since March 13
** Respiratory e-health company says it has received U.S.
FDA 510(k) clearance for Teva Pharmaceutical Industries'
TEVA.TA HFA pressurised metered dose inhaler users to remotely
monitor physiological parameters
** Says clearance is for market application, connecting Teva
inhalers including ProAir® and Albuterol Sulphate with ADR's
Hailie® sensor with physiological parameters
** More than 15 mln shares change hands, twice the 30-day
average volume
** Stock down 25% this year, as of last close
(Reporting by Poonam Behura in Bengaluru)
((Poonam.Behura@thomsonreuters.com;))